Actoxumab - HY-P99277
Nur noch %1 verfügbar
Catalog #
HY-P99277
Ab
413,00 €
Actoxumab (Anti-C. difficile Toxin A Recombinant Antibody) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile. Actoxumab has synergy effect with Bezlotoxumab (HY-P9929) targeting TcdB[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P99277/Actoxumab-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Dry Ice |
| Application | COVID-19-immunoregulation |
| Alternative Names | Anti-C. difficile Toxin A Recombinant Antibody |
| CAS | 1245634-25-6 |
| Storage | Store at -80°C for 2 years |
| MWT | 145.9 (kDa) |
| Solubility | 10 mM in DMSO |
| Clinical Information | No Development Reported |
| Target | Others |
| Application: | COVID-19-immunoregulation |
|---|